Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Future Growth Projections For The Pentavalent Market Size?

The growth trajectory of the pentavalent market has been consistent over the past few years. The market is projected to expand from $2.62 billion in 2024 to $2.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.4%. The historic growth period can be linked to several factors such as worldwide immunization movements, government-supported vaccination drives, efforts to prevent numerous diseases, enhanced public health consciousness, as well as global alliances and financial backing.

The market size for the pentavalent vaccine is projected to experience consistent growth in the coming years. The prediction is of a growth up to “$3.24 billion by 2029, with a compound annual growth rate (CAGR) of 4.6%. The factors contributing to the growth during the forecast period are ongoing global immunization campaigns, enlarged vaccine programs, geographic expansions, strides in research and development, and partnerships focused on vaccine accessibility. Noteworthy trends anticipated throughout the forecast period encompass global health drives and financial backing, public outreach and education initiatives, government guidelines and regulatory structures, and technological advancements in vaccine production.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp

Which Demand Drivers Are Strengthening The Pentavalent Market?

The escalating incidence of diphtheria is projected to propel the expansion of the pentavalent market. The bacterium known as Corynebacterium diphtheriae leads to the extremely contagious and severe disease called diphtheria, which creates substantial difficulties in eating and breathing, along with potential skin ulcers. Children are safeguarded from Diphtheria diseases by the pentavalent vaccine used in a 3-dose schedule immunization, thereby escalating the demand for pentavalent vaccines due to the increasing incidences of diphtheria. For example, in 2022, the World Health Organization, a Switzerland-based United Nations specialized agency, reported an unusually large number of diphtheria cases through the International Health Regulations (IHR) reporting process, predominantly in June and August 2022. Seven countries reported 144 cases of diphtheria, with a significant proportion being among asylum seekers. Of these 144 patients, 69% were found to be clinically compatible, 31% were confirmed to be toxigenic diphtheria cases by laboratory evidence, and 2% were suspected cases. Consequently, the escalating prevalence of diphtheria is catalyzing the growth of the pentavalent market.

Which Sub-Segments Are Driving Growth Within The Pentavalent Market?

The pentavalent market covered in this report is segmented –

1) By Type: Sodium Stibogluconate, Meglumine Antimoniate

2) By Formulation Type: Lyophilized, Liquid

3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Sodium Stibogluconate: Injectable Form, Oral Form, Other Formulations

2) By Meglumine Antimoniate: Injectable Form, Oral Form, Other Formulations

What Future-Focused Trends Are Anticipated In The Pentavalent Market?

The pentavalent market is currently witnessing a trend toward product innovation. Major firms in this market are focusing on creating novel products to solidify their market stance. For instance, Pfizer, a pharmaceutical company based in the US that operates in the pentavalent vaccines market, received approval from The United States Food and Drug Administration in December 2022. This approval was for Pfizer’s experimental Pentavalent Meningococcal Vaccine Candidate (MenABCWY) for teenagers, which is intended to prevent meningococcal disease in people aged 10 to 25. The MenABCWY vaccine’s unique feature is its fusion of the components of two different vaccines, offering protection against the majority of invasive meningococcal diseases’ causing serogroups.

Who Are The Dominant Players In The Pentavalent Market Today?

Major companies operating in the pentavalent market include Pfizer Inc., Merck & Co Inc., Sanofi SA, GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, PT Bio Farma (Persero), Shantha Biotechnics Limited, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, PanGen Biotech Inc., Bharat Biotech International Limited, Vacsera Ltd., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

How Do Regional Dynamics Influence The Pentavalent Market Performance?

Asia-Pacific was the largest region in the pentavalent market in 2024. The regions covered in the pentavalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9104&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model